Insider Trading June 2, 2026 06:30 PM

Atmus Filtration SVP Sells Shares Amid Company Developments

Executive transactions and recent financial reporting provide mixed signals for NASDAQ-listed ATMU.

By Priya Menon ATMU

Charles Masters, Senior Vice President of Atmus Filtration Technologies Inc., executed a sale of company stock totaling $130,763. This transaction occurred while the stock experienced volatility but was set against a backdrop of positive corporate news, including an earnings beat and a declared dividend. The firm also announced a key leadership appointment.

Atmus Filtration SVP Sells Shares Amid Company Developments
ATMU

Key Points

  • The company reported an EPS of $0.69 in Q1 2026, beating expectations and signaling strong operational performance.
  • Management has appointed Kevin Carpenter as SVP and Chief Supply Chain Officer, adding deep global industrial expertise to the leadership team.
  • Analysts view ATMU as potentially undervalued, with price targets suggesting significant upside potential between $58 and $73.

Charles Masters, the Senior Vice President at Atmus Filtration Technologies Inc., recently sold 2,890 shares of the company's common stock on June 1, 2026. This single transaction amounted to $130,763, with each share purchased and subsequently sold at a price of $45.247.

The timing of this sale occurred during a week when ATMU's stock was facing considerable pressure, having declined by nearly 6% over that period. Despite the initial dip, the shares have since shown signs of recovery, trading at $47.25.

According to details provided regarding the disposition of these shares, the sale was necessary following the vesting of the first half of a launch grant award. The proceeds were specifically utilized to cover the reporting person's required tax withholding obligation related to the grant.

Following this recorded transaction, Mr. Masters maintains a direct holding of 43,579 shares of Atmus Filtration Technologies common stock. This information provides a snapshot of the executive's current stake in the company.


Analysis of Valuation and Market Sentiment

Despite the recent insider activity, other indicators suggest potential value for ATMU. Analysis provided by InvestingPro indicates that ATMU may currently be undervalued at its existing market price. Furthermore, professional analysts have established a range of price targets for the stock, spanning between $58 and $73.

The platform also highlighted positive shifts in analyst sentiment, noting that three separate analysts had recently revised their earnings estimates upwards. This data point is part of a larger collection, which includes more than 12 ProTips designed to offer deeper market insights for potential investors.


Recent Corporate and Financial Milestones

Atmus Filtration Technologies has also reported several significant operational and financial achievements recently. For the first quarter of 2026, the company announced an earnings per share (EPS) of $0.69. This figure surpassed analyst expectations, which had projected an EPS of $0.65. The positive earnings surprise represents a considerable increase of 6.15% over initial projections.

In addition to strong quarterly performance, Atmus Filtration announced a cash dividend for the quarter. Shareholders are set to receive a dividend of $0.055 per common share. This payment is scheduled to be payable on June 10, 2026, provided that they are recorded as shareholders by May 26, 2026.


Leadership and Operational Developments

In terms of corporate structure and leadership, the company appointed Kevin Carpenter as its Senior Vice President and Chief Supply Chain Officer. Mr. Carpenter brings a substantial background exceeding 25 years in global industrial organizations. His prior professional experience includes time spent at The Toro Company.

These various recent developments, spanning financial performance, executive transactions, dividend declarations, and key leadership hires, collectively underscore Atmus Filtration's strategic movements across both its financial health and organizational structure.


Key Takeaways for Investors

Risks

  • The stock experienced a sharp decline of nearly 6% during the week preceding the insider sale, indicating short-term market volatility.
  • An SVP sold shares following an award vesting to cover tax withholding, which is a transaction that some investors monitor for potential negative signals.
  • While not explicitly stated as a risk, the reliance on analyst projections (e.g., $58-$73 targets) suggests valuation remains dependent on future performance and market confidence.

More from Insider Trading

Rackspace Technology Executive Offloads Shares to Cover Tax Obligations Amid Stock Surge Jun 4, 2026 Fermi Inc. Executive Unloads $1M in Shares Amid Ongoing Corporate Restructuring Jun 4, 2026 Veracyte Executive Sells Nearly $700K in Shares Amid Product Rollouts and Analyst Upgrades Jun 4, 2026 Veracyte Executive Traces Share Disposition Amid Clinical Milestones and Valuation Scrutiny Jun 4, 2026 Veracyte CFO Executes $177K Stock Sale Amid Clinical Trial Updates and Analyst Revisions Jun 4, 2026